Date | 9/30/2024 | 7/31/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 7/31/2023 | 6/30/2023 | 12/31/2022 |
---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $28,300,000.00 | -- | -- | -- | $1,383,000.00 | -- | -- | -- | -- |
Accounts Receivable Net Current | $90,000.00 | -- | -- | -- | $71,000.00 | -- | -- | -- | -- |
Inventory | $4,139,000.00 | -- | -- | -- | $3,322,000.00 | -- | -- | -- | -- |
Prepaid Expenses and Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Total Current Assets | $35,030,000.00 | -- | -- | -- | $5,185,000.00 | -- | -- | -- | -- |
Property Plant and Equipement | $1,572,000.00 | -- | -- | -- | $1,487,000.00 | -- | -- | -- | -- |
Intangible Assets Net | $26,061,000.00 | -- | -- | -- | -- | -- | -- | -- | -- |
Goodwill | $44,300,000.00 | -- | -- | -- | -- | -- | -- | -- | -- |
Other Assets | $16,000.00 | -- | -- | -- | $23,000.00 | -- | -- | -- | -- |
Total Assets | $107,196,000.00 | -- | -- | -- | $6,825,000.00 | -- | -- | -- | -- |
Accounts Payable | $4,419,000.00 | -- | -- | -- | $3,830,000.00 | -- | -- | -- | -- |
Accrued Liabilities | $2,910,000.00 | -- | -- | -- | $3,048,000.00 | -- | -- | -- | -- |
Total Current Liabilities | $30,635,000.00 | -- | $5,000.00 | -- | $5,000.00 | -- | -- | -- | -- |
Long Term Debt | $13,750,000.00 | -- | -- | -- | $38,268,000.00 | -- | -- | -- | -- |
Additional Paid-in Capital | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Accumulated Other Comprehensive Loss | $-9,000.00 | -- | -- | -- | $17,000.00 | -- | -- | -- | -- |
Accumulated Deficit | $-13,200,000.00 | -- | $-2,139,199.00 | -- | $-5,000.00 | -- | -- | -- | -- |
Total Stockholders' Equity | $76,561,000.00 | $-148,315,000.00 | $-5,000.00 | $-5,000.00 | $-5,000.00 | $-123,507,000.00 | -- | $-112,876,000.00 | $-95,877,000.00 |
Controlling Interest in Subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Total Liabilities and Equity | $107,196,000.00 | -- | -- | -- | -- | -- | -- | -- | -- |
Date | 9/30/2024 | 7/31/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 7/31/2023 | 6/30/2023 | 12/31/2022 |
---|---|---|---|---|---|---|---|---|---|
Total Revenues | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Cost of Revenues | $414,000.00 | $1,381,000.00 | -- | -- | -- | $972,000.00 | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Research and Development | $1,217,000.00 | $7,585,000.00 | -- | -- | -- | $4,418,000.00 | -- | -- | -- |
Selling, General, and Administrative | $2,926,000.00 | $13,047,000.00 | -- | -- | -- | $8,234,000.00 | -- | -- | -- |
Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Loss from Operations | $-4,425,000.00 | $-21,680,000.00 | -- | -- | $-5,000.00 | $-22,609,000.00 | -- | -- | -- |
Loss Before Income Taxes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Earnings Per Share Basic | $0.18 | $-26.08 | $-713,794.00 | -- | $-5,000.00 | $-14.15 | -- | -- | -- |
Weighted Average Shares Basic | 14,057,636 | -- | 1 | -- | 1 | 759,489 | -- | -- | -- |
Earnings Per Share Diluted | $0.02 | $-26.08 | $-713,794.00 | -- | $-5,000.00 | $-14.15 | $-14.15 | $-22.67 | $-31.50 |
Weighted Average Shares Diluted | 16,057,636 | 815,854 | 1 | -- | 759,814 | 759,489 | 760,572 | 758,942 | 751,568 |
Common Stock Shares Authorized | 210,000,000 | 6,594,946 | 1,000 | -- | 6,594,946 | -- | -- | -- | -- |
Common Stock Shares Outstanding | 14,535,136 | 13,387,636 | -- | -- | 1 | -- | -- | -- | -- |
Common Stock Value | $1,000.00 | -- | -- | -- | -- | -- | -- | -- | -- |
Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | -- | $0.00 | -- | -- | -- | -- |
Payments Of Dividends Common Stock | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Shares Authorized | 20,000,000 | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Shares Outstanding | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Value | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | -- | -- | -- | -- | -- | -- | -- |
Share Price | -- | -- | -- | -- | -- | -- | -- | -- | -- |